Roseville, MN – Friday, June 17, 2022 – Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, participated recently at the annual investor conference, “LD Micro Invitational.” Speaking on behalf of Calyxt was President and CEO Michael A. Carr.
| Calyxt, Inc @ the LD Micro Invitational | |
| Date: | Wednesday, June 8, 2022 |
| Time: | 10:30 a.m. ET (7:30 a.m. PT) |
| Webcast: | Link to view event |
The presentation is available for viewing and replay on the link above.
To schedule or learn about additional investor conversations with Calyxt, please reach out to investors@calyxt.com.
Calyxt (Nasdaq: CLXT) is a plant-based synthetic biology company. The Company leverages its proprietary PlantSpring™ technology platform to engineer plant metabolism to produce innovative high value plant-based chemistries for use in customers’ materials and products. As plant-based solutions, the Company’s synthetic biology products can be used in helping customers meet their sustainability targets and financial goals. Calyxt’s diversified offerings are primarily delivered through its proprietary BioFactory™ production system. For more information, visit www.calyxt.com.
PlantSpring, BioFactory, and the Calyxt logo are trademarks of Calyxt, Inc.
Contacts:
| Calyxt Media Contact: | Calyxt Investor Relations Contact: |
| Brennan Burks/ David Rosen/ John Garabo/ Michael Barron Calyxt Communications/Argot Partners (212) 600-1902 media@calyxt.com | Kimberly Minarovich/ Cameron Willis Argot Partners (212) 600-1902 investors@calyxt.com |
| Calyxt Business Development Contact: | |
| Gerry Nuovo Senior Vice President of Business Development (612) 427-7881 gerry.nuovo@calyxt.com |
